معرفی
Professor Chris Day is a leading academic at Newcastle University, with a focus on liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. His research spans genetics, biomarker discovery, and lifestyle interventions, often involving international collaborations.
- Affiliation: Newcastle University
- Academic Rank: Professor
Research Interests:
Professor Day investigates the genetic and environmental factors driving liver disease progression, including inflammation, fibrosis, and cardiometabolic complications. His work emphasizes the role of polymorphisms (e.g., PNPLA3, TM6SF2), non-invasive diagnostic tools (e.g., FibroTest), and interventions like exercise and dietary modifications.
Recent Article Trends:
His recent publications analyze genetic risk scores for cirrhosis, lipid metabolism in inflammation, and the impact of aging on fibrosis diagnosis. These studies highlight cross-disciplinary themes in genomics, metabolomics, and clinical epidemiology.
Scientific Contributions:
Key contributions include validating biomarkers for liver fibrosis, exploring the gut-liver axis in type 2 diabetes, and leading clinical trials on antifibrotic therapies (e.g., losartan). His work bridges translational research and public health applications.
